https://orcid.org/0000-0003-4503-9382
Figures & data
Figure 1 Relationship between Nontreponemal IgM Antibodies and the Staging of Latent Syphilis Patients. (A) Distribution of clinical phases among patients with different nontreponemal IgM antibodies results. (B) Nontreponemal IgM antibodies correlate with the staging of latent syphilis patients.
Figure 2 The Nomogram Model for Predicting Latent Syphilis Staging.
Figure 3 Receiver-Operating Characteristic Curves for Evaluating the Predictive Accuracy of the Latent Syphilis Staging Model. (A) Receiver-Operating Characteristic Curves for the Model in the Training Set. (B) Receiver-Operating Characteristic Curves for the Model in the Validation Set.
Figure 4 Calibration Curve for Validating the Latent Syphilis Staging Model. (A) Calibration Curve for the Model in the Training Set. (B) Calibration Curve for the Model in the Validation Set.
Figure 5 Decision Curve Analysis and Clinical Impact Curve for Evaluating the Clinical Utility of the Latent Syphilis Staging Model. (A) Decision Curve Analysis of the Model in the Training Set. (B) Clinical Impact Curve of the Model in the Training Set. (C) Decision Curve Analysis of the Model in the Validation Set. (D) Clinical Impact Curve of the Model in the Validation Set.
